Fellow explorer! We are currently migrating content published before 2024. Archives of our old website are available at Wayback Machine.

Adapted Pig Kidneys for Xenotransplantation Clinical Trials

Background

Currently, over 90,000 people are waiting for a kidney transplant in the United States alone [1]. End-stage renal disease affects 2 in 1000 Americans, whose only treatment options are dialysis or a kidney transplant [2]. Dialysis does the work of the kidneys by filtering out waste and excess fluid. However, serious drawbacks include frequent, time-consuming appointments and an increased risk of blood clots, which cause dialysis to fail [3]. Therefore, the ideal treatment option is transplantation of a functioning kidney.

A Prospective Outlook on Tackling Acute Kidney Injury: from Diagnosis to Treatment

Acute kidney injury (AKI) is a common complication found in hospitals and the third leading cause of death among trauma patients. While there exists a wide variety of causes for AKI, they can be attributed to few pathophysiologies that studies are exploring medications to target. In conjunction with improving treatments, however, there is also a need to improve AKI diagnosis to prevent late-stage complications. This review will explore developments of new diagnostic biomarkers and medications that address these concerns.